Official announcements
messages in brief
|
13/08/2010
The Federal Office for Safety in Health Care (BASG) publishes the following statement on "Calcium Supplementation and Myocardial Infarction Risk." It refers to a meta-analysis on the use of calcium as monotherapy for osteoporosis published in the…
messages in brief
|
11/08/2010
Further information: Download guide
messages in brief
|
16/07/2010
Children's health depends to a large extent on the availability of appropriate medicines. Half of the medicines used to treat 100 million children and adolescents in the EU have not been adequately tested and approved for them. Rather, medicines are…
messages in brief
|
23/06/2010
In Federal Law Gazette II No. 180/2010, the Federal Minister of Health made use of the power to issue an ordinance pursuant to Section 48 (3) AMG and issued the Ordinance on the Conduct of Non-interventional Studies. This ordinance stipulates that…
messages in brief
|
10/06/2010
The Federal Office for Safety in Health Care (BASG) / AGES PharmMed provides information on holders and carrier arms. Wall mountsA user in Austria was injured after an image intensifier mounted with a height-adjustable bracket fell off the wall. The…
messages in brief
|
02/06/2010
According to § 68 of the Medical Devices Act (MPG), Federal Law Gazette No. 657/1996, last amended by Federal Law Gazette I No. 143/2009, the Federal Office for Safety in Health Care (BASG) is responsible, among other things, for monitoring the…
messages in brief
|
21/05/2010
On March 17, 2010, the marketing authorization holder (GlaxoSmithKline Biologicals, GSK) informed the European Medicines Agency (EMA) that the oral vaccine Rotarix is contaminated with DNA of the porcine circovirus (PCV). As an immediate measure, GSK…
messages in brief
|
26/04/2010
Based on a re-evaluation of the safety and efficacy data, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommends the withdrawal of the marketing authorization for all bufexamac-containing medicinal…
messages in brief
|
31/03/2010
AGES PharmMed receives a large number of requests for decentralized procedures (DCP) and mutual recognition procedures (MRP) to act as procedure managing state (RMS). The slot allocation procedure for DCP submissions has been designed to allow for…
messages in brief
|
29/03/2010
On March 29, 2010, the delivery of generic drugs containing Clopidogrel, which used the active ingredient of the supplier Glochem Industries Ltd., was stopped for the time being on wholesale level by BASG/AGES PharmMed. It was determined that the…